Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,010 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $338.12 | 25 | $0 (2024) |
| ABBVIE INC. | $254.05 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $174.21 | 10 | $0 (2024) |
| PFIZER INC. | $171.36 | 8 | $0 (2024) |
| UCB, Inc. | $160.12 | 3 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $111.19 | 8 | $0 (2023) |
| RedHill Biopharma Inc. | $111.03 | 1 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $98.17 | 9 | $0 (2017) |
| Janssen Biotech, Inc. | $94.66 | 6 | $0 (2024) |
| Allergan Inc. | $83.83 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $311.98 | 15 | ABBVIE INC. ($90.27) |
| 2023 | $624.48 | 30 | Celgene Corporation ($136.93) |
| 2022 | $282.41 | 13 | Celgene Corporation ($171.38) |
| 2021 | $79.47 | 4 | ABIOMED ($33.80) |
| 2020 | $65.82 | 4 | Janssen Biotech, Inc. ($24.52) |
| 2019 | $188.84 | 9 | Boston Scientific Corporation ($74.35) |
| 2018 | $217.60 | 16 | Allergan Inc. ($66.81) |
| 2017 | $239.47 | 19 | Takeda Pharmaceuticals America, Inc. ($98.17) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/28/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Neuroscience | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Gastroenterology | ||||||
| 05/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Gastroenterology | ||||||
| 04/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $39.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/13/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 03/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/28/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Biosimilars | ||||||
| 02/08/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2023 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2023 | Olympus America Inc. | EndoClot PHS (Device) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Endotherapy | ||||||
| 11/06/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $134.41 | General |
| 08/18/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 08/02/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 459 | 581 | $192,272 | $39,015 |
| 2022 | 14 | 528 | 656 | $233,313 | $44,023 |
| 2021 | 14 | 455 | 575 | $208,404 | $44,206 |
| 2020 | 17 | 453 | 491 | $175,588 | $36,721 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 55 | 55 | $56,375 | $10,613 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 66 | $17,160 | $6,039 | 35.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 74 | 157 | $21,195 | $3,521 | 16.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 50 | $30,500 | $3,239 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,270 | $3,052 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $11,385 | $3,033 | 26.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $11,600 | $2,669 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 27 | $7,020 | $2,442 | 34.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $10,740 | $1,165 | 10.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,120 | $930.55 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 15 | $2,700 | $901.80 | 33.4% |
| 43450 | Dilation of esophagus | Facility | 2023 | 16 | 17 | $7,225 | $509.99 | 7.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 40 | 47 | $1,410 | $486.45 | 34.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 40 | 47 | $1,363 | $357.67 | 26.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 11 | 11 | $209.00 | $55.88 | 26.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 60 | 60 | $61,500 | $11,492 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 78 | $20,280 | $6,848 | 33.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 72 | 173 | $23,355 | $4,198 | 18.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $13,860 | $4,091 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $16,985 | $4,077 | 24.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 63 | 63 | $37,430 | $3,936 | 10.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 45 | $11,700 | $3,448 | 29.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $7,975 | $1,773 | 22.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $25,060 | $1,654 | 6.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $4,420 | $1,196 | 27.1% |
About Dr. Rajesh Gupta, MD
Dr. Rajesh Gupta, MD is a Gastroenterology healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750368239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajesh Gupta, MD has received a total of $2,010 in payments from pharmaceutical and medical device companies, with $311.98 received in 2024. These payments were reported across 110 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,010).
As a Medicare-enrolled provider, Gupta has provided services to 1,895 Medicare beneficiaries, totaling 2,303 services with total Medicare billing of $163,965. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location High Point, NC
- Active Since 12/27/2005
- Last Updated 09/17/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1750368239
Products in Payments
- ZEPOSIA (Drug) $338.12
- XIFAXAN (Drug) $162.18
- XELJANZ (Drug) $122.68
- RINVOQ (Biological) $117.54
- Talicia (Drug) $111.03
- LINZESS (Drug) $96.73
- STELARA (Biological) $81.71
- AUTOTOME (Device) $74.35
- CLENPIQ (Drug) $64.55
- SKYRIZI (Biological) $57.92
- Dexilant (Drug) $56.37
- Entyvio (Biological) $49.36
- GATTEX (Drug) $49.25
- VELSIPITY (Drug) $34.40
- REBYOTA (Biological) $34.30
- Impella (Device) $33.80
- Cook Medical Biliary (Device) $31.10
- Humira (Biological) $29.35
- Cimzia (Drug) $25.71
- MOTEGRITY (Drug) $23.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in High Point
Albert Rhoton, Md, MD
Gastroenterology — Payments: $137,213
Shabana Shahid, M.d, M.D
Gastroenterology — Payments: $27,647
Radha Menon, M.d, M.D
Gastroenterology — Payments: $9,134
John Walker, Md, MD
Gastroenterology — Payments: $5,615
Christopher Benson, M.d, M.D
Gastroenterology — Payments: $203.95
Tri Le, Md, MD
Gastroenterology — Payments: $76.89